Research Article
Resection of Nonalcoholic Steatohepatitis-Associated Hepatocellular Carcinoma: A Western Experience
Table 2
Surgical series of NASH-associated HCCs (≥5 patients).
| | | n | Age (years) | Gender (M : F) | Tumor size (cm) | Primary Tx | Cirrhosis (%) | Recurrence (%) |
| | Hashizume et al. [15] | 9 | 71.5** | 6 : 3 | 3.8* | LR 67%, RFA 22%, TAE 11% | 67 | 11.1 | | Kawada et al. [16] | 6 | 73** | 3 : 3 | 3.5** | LR 100% | 0 | N.R. | | Malik et al. [17] | 17 | 63.1* | 12 : 5 | 3.4* | LT 100% | 100 | 5.9 | | Tokushige et al. [18] | 16 | N.R. | N.R. | N.R. | LR 81%, RFA 18% | N.R. | 88 | | Takuma and Nouso [19] | 11 | 73.8* | 6 : 5 | 3.3* | LR 64%, RFA 27%, MCT 9% | 36 | 60a |
|
|
LR: liver resection, RFA: radiofrequency ablation, TAE: transarterial embolization, LT: liver transplant, MCT: microwave coagulation therapy.
*Mean, **median, arecurrence-free survival.
|